A. V. Soerensen, “A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2”, AO, vol. 55, no. 3, pp. 341–348, Mar. 2016.